Europe has approved a new indication for sorafenib tosylate tablets (Nexavar) and an expanded indication for darbepoetin alfa (Aranesp); Japan has approved idursulfase solution (Elaprase). Medscape Medical News
Although the results were modest, a meta-analysis found that activity-related interventions and psychological counseling were able to reduce the incidence of fatigue in patients with cancer. Medscape Medical News
A population-based study found better survival for localized prostate cancer patients who received curative therapy than for those who underwent watchful waiting. Medscape Medical News
Emerging anti-telomerase therapies that are currently in clinical trials might prove useful against some forms of human cancers. Laboratory Investigation
In this Special Report, expert hematologists address the pros and cons of current therapies for myelodysplastic syndrome-related thrombocytopenia and detail promising investigational approaches. Medscape Hematology-Oncology
Second-generation patients with breast, lung, prostate, or colon cancer may face an increased risk for early mortality if their parents died within 10 years of their own cancer diagnosis. Medscape Medical News
